Invesaro

Stocks NSIT Financial statements

Financial statements

INSIGHT ENTERPRISES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data INSIGHT ENTERPRISES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue5,4866,7047,0807,7318,3419,43610,4319,1768,7028,247
Cost of revenue4,7425,7856,0866,5937,0417,9898,7957,5066,9366,486
Gross profit7439199941,1381,3001,4481,6371,6701,7661,761
Selling, general and administrative5857237578811,0141,1171,2171,2361,3431,386
Operating income149179233241272332414420389335
Interest expense8.631821.728.541.640.539.541.15884.8
Interest income1.071.211.08
Other non-operating income-1.29-2.2-21.6-0.4-1.531.010.23-0.822.37-24.3
Pre-tax income139159212212228293374378333226
Income tax54.868.448.252.355.873.293.896.583.268.5
Net income84.790.7164159173219281281250157
EBITDA187222271287337387470482487441
EPS, basic2.352.544.604.494.926.278.048.537.735.00
EPS, diluted2.322.504.554.434.875.957.667.556.554.86
Shares, basic (weighted)36.135.735.635.535.13534.93332.331.5
Shares, diluted (weighted)36.436.2363635.436.936.637.238.132.3

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents203106143115128104164269259358
Receivables1,4371,8151,9322,5112,6852,9373,2723,5684,1725,517
Inventory148195149191186328265185123161
Other current assets127152116231177200192189209261
Total current assets1,9842,3042,3393,0483,1763,5683,9014,3314,8456,362
Property, plant and equipment70.975.373131146176204210216188
Lease right-of-use assets72.676.28576.573.2
Goodwill62.61311674154294284936848941,170
Intangible assets20.7101112279247215205370426426
Other non-current assets29.156.885.4306312301149146135123
Total assets2,2192,6862,7764,1784,3114,6895,1136,2867,4499,087
Accounts payable1,0708999781,2761,4611,7801,7852,2553,0604,264
Accrued liabilities152176253352408423434538512615
Deferred revenue61.18962.3
Short-term debt0.4816.61.41.691.110.043463483330.01
Total current liabilities1,4391,5001,5371,8842,2272,5152,8663,3734,1225,104
Long-term debt40.32971968584383622925935311,361
Lease liabilities58.463.37165.960.4
Other non-current liabilities2644.956.1232270256157203161187
Total liabilities1,5061,8421,7893,0182,9683,1803,4754,5515,6787,438
Total debt40.73131978594393626389418641,361
Paid-in capital310317324357364368328329343165
Retained earnings4605507058419931,1681,3691,4481,5091,520
Shareholders' equity7138439871,1601,3421,5091,6381,7361,7711,649
Total equity7138439871,1601,3421,5091,6381,7361,7711,649
Total liabilities and equity2,2192,6862,7764,1784,3114,6895,1136,2867,4499,087
Shares outstanding35.535.835.535.335.134.93432.631.831

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income84.790.7164159173219281281250157
Depreciation and amortization38.142.637.546.265.655.456.662.598.1106
Stock-based compensation11.112.815.41617.718.222.7293433.7
Deferred income tax10.519.19.137.42-13.211.9-9.25-13.18.31.89
Change in receivables-169-208-46.9-119-133-289-406-11.9-656-1,160
Change in inventory-50.7-1446.511.91.03-14953.775.754.4-37.4
Change in payables194-23729.8-0.6115230353.62168261,047
Cash from operations96.1-30729312835616498.1620633304
Capital expenditures-12.3-19.2-17.3-69.1-24.2-52.1-70.9-39.3-46.8-24.5
Acquisitions-10.3-187-74.9-664-6.410-68.2-481-270-285
Cash from investing-21.2-205-91.7-7339.71-21.1-138-505-303-310
Debt issued175
Debt repaid-8.75-166
Share buybacks-50-22.1-27.9-25-50-108-217-200-151
Cash from financing-58.2397-159578-362-161114-16.7-32182.3
Exchange rate effect-1.9416.1-5.06-0.0910.8-5.86-14.57.45-17.623
Net change in cash14.7-98.536.8-2814.3-24.659.7105-9.3299.3
Free cash flow83.8-32627558.833111227.2580586279
Interest paid3.781110.26.2516.68.8516.328.335.270
Income taxes paid39.155.531.242.562.57691.510411874.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $159.03 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin22.1%Gross profit / revenue.
Operating margin4.6%Operating income / revenue.
EBITDA margin5.9%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin3.5%Pre-tax income / revenue.
Net margin2.5%Net income / revenue.
FCF margin4.6%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin4.9%Cash from operations / revenue.
Effective tax rate29.5%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)13.1%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)1.8%Net income / average total assets.
Return on invested capital (ROIC)10.1%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue17.1%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.4%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.3%Capital expenditures / revenue.
D&A / revenue1.3%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-5.2%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-7.5%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-0.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-0.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y2.5%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y6.3%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-13.8%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-6.8%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y4.3%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-9.3%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-2.1%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y5.5%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-37.0%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-17.5%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y-1.8%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-25.8%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-14.1%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y-0.0%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-52.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y45.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-3.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-52.3%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y117.4%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-3.4%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-6.9%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y0.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y4.2%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y22.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y21.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y16.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-15.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-4.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.8%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.18xCurrent assets / current liabilities.
Quick ratio1.10x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.05x(Cash + short-term investments) / current liabilities.
Debt / equity0.92xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets12.9%Total debt / total assets.
Liabilities / assets85.9%Total liabilities / total assets.
Net debt$1.11BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA2.21xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage4.12xOperating income / interest expense.
Working capital$1.36BCurrent assets - current liabilities.
Goodwill and intangibles / assets13.6%(Goodwill + intangible assets) / total assets.
Tangible book value$55.0MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.75xRevenue / average total assets.
Fixed asset turnover46.0xRevenue / average property, plant and equipment.
Inventory turnover27.0xCost of revenue / average inventory.
Days inventory14 days365 x average inventory / cost of revenue.
Receivables turnover1.10xRevenue / average receivables.
Days sales outstanding333 days365 x average receivables / revenue.
Days payables356 days365 x average accounts payable / cost of revenue.
Cash conversion cycle-10 daysDays inventory + days sales outstanding - days payables.
FCF conversion188.4%Free cash flow / net income, when net income is positive.
Capex / operating cash flow6.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$6.98Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$284.34Revenue / diluted weighted shares.
FCF per share$13.14Free cash flow / diluted weighted shares.
Operating cash flow per share$14.02Cash from operations / diluted weighted shares.
Book value per share$54.38Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$1.86Tangible book value / shares outstanding.
Cash per share$12.32(Cash + short-term investments) / shares outstanding.
Buybacks / FCF56.7%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$4.67BShare price x shares outstanding.
Enterprise value$5.78BMarket cap + total debt - cash - short-term investments.
P/E22.2xMarket cap / net income. Only when net income is positive.
P/S0.54xMarket cap / revenue.
P/B2.91xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book84.8xMarket cap / tangible book value, when positive.
P/FCF11.8xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF11.0xMarket cap / cash from operations, when positive.
EV/Sales0.67xEnterprise value / revenue.
EV/EBIT14.8xEnterprise value / operating income, when both are positive.
EV/EBITDA11.5xEnterprise value / EBITDA, when both are positive.
EV/FCF14.6xEnterprise value / free cash flow, when both are positive.
FCF yield8.5%Free cash flow / market cap.
Earnings yield4.5%Net income / market cap (the inverse of P/E).
Shareholder yield4.8%(Dividends paid + share buybacks) / market cap.
What was INSIGHT ENTERPRISES INC's revenue in fiscal 2025?

INSIGHT ENTERPRISES INC reported revenue of $8.25B for fiscal 2025, 5.2% lower than the year before.

Was INSIGHT ENTERPRISES INC profitable in fiscal 2025?

Yes. Net income was $157.3M, a net margin of 1.9%.

How much free cash flow did INSIGHT ENTERPRISES INC generate in fiscal 2025?

Cash from operations of $303.8M minus capital expenditures of $24.5M left free cash flow of $279.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to INSIGHT ENTERPRISES INC